Results showed that pre-knockdown of SMC5/6 promoted HBeAg and HBsAg expression to varying degrees in the IFNα2 or siHBx treatment groups but had no significant effect on the combination group (Fig. 6D and E), while it did not increase the rates of infection establishment (Fig. S11). The gene discussed is IFNA2; the disease is infection.